Genoplan
PrivateLast Round
Series B
Sep 2, 2018
Total Funding Raised
$17.51M
Company Overview
Genoplan is a biotechnology company that develops genetic test kits and provides personalized health analysis services based on DNA testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genoplan Comparables
Compare Genoplan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WeGene | 85% | |
| Prenetics | 80% | |
| Mapmygenome | 78% | |
Genoplan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2018 | ||||
| Series A | Jan 27, 2016 | ||||
| Accelerator | Jun 22, 2015 | ||||
| Crowdfunding | Mar 19, 2015 | ||||
| Grant | Oct 14, 2014 |
Genoplan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DAYLI Partners | Series B |
| SBVA | Series B, Series A |
| Wonik Investment Partners | Series A |
| Samsung Venture Investment | Series B, Series A |
| Yozma Group | Grant |
| SparkLabs Korea | Series B, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2018
$13M round led by GC Green Cross Holdings.
Genoplan Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genoplan's valuation, stock price, and market status.